Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Statin myopathy as a metabolic muscle disease.

Expert review of cardiovascular therapy - 1 Aug 2008

Phillips Paul S, Haas Richard H

Abstract excerpt

The etiology of statin myopathy remains unclear and concern about this toxicity is a leading reason that statins are underutilized. A number of observations suggest that this toxicity may be due to the metabolic effects of lipid-lowering in patients with minor muscle disorders. These patients have a high frequency of mutations for metabolic muscle diseases and often have depleted mitochondrial enzymes. Their...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fatty Acids
Share to Genetic Predisposition to Disease
Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Muscular Diseases

Share to Oxidation-Reduction

Share to Rhabdomyolysis

Share to Risk Factors

Source

Identifiers

PMID: 18666847
DOI: 10.1586/14779072.6.7.971

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Statin myopathy as a metabolic muscle disease.PMID 18666847Read ↗

Clinical characterization and molecular mechanisms of statin myopathy.Semantic proximity Read ↗

Genetic risk factors associated with lipid‐lowering drug‐induced myopathiesSemantic proximity Read ↗

Metabolic myopathies discovered during investigations of statin myopathy.Semantic proximity Read ↗

Statin-associated myopathy: from genetic predisposition to clinical management.Semantic proximity Read ↗

Genetic predisposition to statin myopathy.Semantic proximity Read ↗

The genetics of statin-induced myopathy.Semantic proximity Read ↗

Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle ComponentsSemantic proximity Read ↗

Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management.Semantic proximity Read ↗

Investigating mitochondrial impairment as a mechanism of statin-induced muscle toxicitySemantic proximity Read ↗

Statin-induced myopathy.Semantic proximity Read ↗

Statin-associated muscle toxicity : clinical and genomic perspectivesSemantic proximity Read ↗

Approach to clinical and genetic characterization of statin-induced myopathy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.